Cathie Wood Just Bought $17 Million of Cerebras Stock. Wall Street Sees 59% Upside.

Nauman Khan

Mon, August 31, 2026 at 5:00 PM GMT+3 4 min read

A photo of Cathie Wood by Caroline Wood via Wikimedia Commons and resized

Cathie Wood is doubling down on Cerebras Systems (CBRS) at a time when the artificial intelligence (AI) chip stock is struggling to regain its footing. Ark Invest bought another 93,290 Cerebras shares on Aug. 25 across multiple exchange-traded funds (ETFs), worth roughly $17.2 million based on the reported purchase value. That follows additional buying earlier in August.

The timing is notable. Shares of Cerebras have fallen sharply from their May peak and remain extremely volatile. CBRS stock is down 7% over the past month and 26% over the past three months. The stock has swung between a 52-week high of $386.34 and a low of $160.81.

More News from Barchart

Why is Wood buying the dip? Let's take a closer look.

www.barchart.com

Cerebras Stock Is Still a High-Growth AI Bet

The answer starts with Cerebras' positioning in the fast-growing AI inference market. Unlike Nvidia (NVDA), which dominates the broader GPU market, Cerebras focuses on wafer-scale computing designed to deliver extremely fast AI inference. That could become increasingly important as businesses move from training AI models toward running them in real time.

Cerebras has also been expanding beyond selling AI accelerators. It is building an inference cloud business and working with major technology companies including OpenAI, Amazon's (AMZN) Amazon Web Services (AWS), and Advanced Micro Devices (AMD).

The company recently unveiled its CS-4 system, which it says can deliver up to 30 times faster inference than GPU-based alternatives. Cerebras is also working with AMD on a disaggregated inference architecture that can deliver up to five times higher throughput per watt in certain configurations.

That gives Wood a larger thesis than simply betting on another chip company. She is effectively betting that AI inference becomes one of the biggest infrastructure markets of the next decade.

Cerebras' Valuation Leaves Little Room for Error

The biggest risk is valuation. Cerebras currently has a market capitalization of about $42.5 billion and annual sales of roughly $510 million. The price-to-sales (P/S) ratio is 60 times, an enormous premium for a company that is still losing money on a GAAP basis.

Cerebras therefore needs exceptional revenue growth to justify its valuation. Fortunately for the bulls, that growth is materializing.

Q2 Results Show Why Wood Keeps Buying

Cerebras reported second-quarter revenue of $180.1 million, up 74% year-over-year (YOY), while core revenue reached $209.9 million, up 103% YOY.

The strongest part of the business was its cloud operation. Core cloud and other services revenue jumped 287% YOY to $127.7 million. Core gross margin improved to 41%.

For full-year fiscal 2026, management raised its core revenue guidance to $880 million to $890 million. Cerebras also expects Q3 core revenue of $214 million to $216 million.

Perhaps more importantly, Cerebras ended the quarter with $8.6 billion in cash, restricted cash, and short-term investments and reported $25.4 billion in remaining performance obligations. The company also has more than 600 megawatts of data-center capacity live or under contract.

Those numbers help explain Wood's aggressive buying. She is looking beyond near-term losses toward the company's potential scale.

Wall Street Remains Bullish on CBRS Stock

Wood is not alone in her conviction. Overall, CBRS stock has a consensus "Strong Buy" rating based on 11 analysts. Of those analysts, eight have a "Strong Buy," one has a "Moderate Buy" rating, and two recommend a "Hold" rating. The average price target of $283.91 indicates roughly 59% potential upside from current levels, while the high target of $330 represents a possible 84% climb from here.

UBS recently maintained its "Buy" rating and $330 target on Cerebras, while Morgan Stanley raised its target to $279 from $273 while keeping an "Overweight" rating. Wedbush also lifted its target to $290 from $280 with an "Outperform" rating.

The message from Wall Street is straightforward. Cerebras remains a speculative AI stock, but analysts believe its growth, cloud expansion, and inference advantage could ultimately justify its premium valuation. Wood appears to be willing to take that bet while CBRS stock is down sharply from its highs.